Biomedicines (Aug 2024)

Nesfatin-1: A Novel Diagnostic and Prognostic Biomarker in Digestive Diseases

  • Adriana-Cezara Damian-Buda,
  • Daniela Maria Matei,
  • Lidia Ciobanu,
  • Dana-Zamfira Damian-Buda,
  • Raluca Maria Pop,
  • Anca Dana Buzoianu,
  • Ioana Corina Bocsan

DOI
https://doi.org/10.3390/biomedicines12081913
Journal volume & issue
Vol. 12, no. 8
p. 1913

Abstract

Read online

Nesfatin-1, deriving from a precursor protein, NUCB2, is a newly discovered molecule with anti-apoptotic, anti-inflammatory, antioxidant, and anorexigenic effects. It was initially identified in the central nervous system (CNS) and received increasing interest due to its energy-regulating properties. However, research showed that nesfatin-1 is also expressed in peripheral tissues, including the digestive system. The aim of this review is to give a résumé of the present state of knowledge regarding its structure, immunolocalization, and potential implications in diseases with inflammatory components. The main objective was to focus on its clinical importance as a diagnostic biomarker and potential therapeutic molecule in a variety of disorders, among which digestive disorders were of particular interest. Previous studies have shown that nesfatin-1 regulates the balance between pro- and antioxidant agents, which makes nesfatin-1 a promising therapeutic agent. Further in-depth research regarding the underlying mechanisms of action is needed for a better understanding of its effects.

Keywords